New material could lead to ‘stem cell factories’

As co-author Chris Denning explains in a video press release on the study, the average patient loses around five billion cells during a heart attack. This allows them to fix the damage caused by heart attacks.

On the other hand, by making “stem cell factories” possible, regenerative medicine is provided with the main product without the costs and ethical implications that usually come with using actual human stem cells. This could benefit patients who are now undergoing similar procedures.

Stem cells that are pluripotent can develop into any kind of cell, from bone and nerves to heart tissue. The entire process envisioned shows the perspective of being scalable, thus allowing for the rapid development of affordable stem cell-based treatments.

The capacity to grow billions of cells easily and quickly might possibly lead to great advances in the restorative treatments for numerous injuries and conditions.

“The possibilities for regenerative medicine are still being researched in the form of clinical trials. What we are doing here is paving the way for the manufacture of stem cells in large numbers when those therapies are proved to be safe and effective”, Morgan Alexander, professor of biomedical surfaces at University of Nottingham, said.

This man-made material is a breakthrough in the field, as researchers discovered that its most important quality is being free from possible batch variability or contamination. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

However, according to a new study, stem cells factories will soon become a reality, offering better chances for individuals all across the globe.

Denning predicts that synthetic stem cell growing material could be used to help patients in as little as two or three years.

The University of Nottingham have said in an online statement on its website that the new material could be an off the shelf product for use in treating the brain, liver and heart. This is because it contains cells called hepatocytes that are capable of self-renewal following injury.

Stem cells can be found in both adult and embryonic varieties.

Upcoming events already accessible through stemcellconference.org include the Global Stem Cells Group Regenerative Medicine Symposiums to be held September 3 in Santiago, Chile; October. 9 in Barcelona, Spain; October. 15 in Buenos Aires, Argentina; and March 19, 2016 in San Jose, Costa Rica.